Invitrogen™ pVAX1 Vector

Catalog No.	Quantity
V26020	20 μg

Catalog No. V26020

Supplier: Invitrogen™ V26020

Description

Includes

20μg of each pVAX1 and expression control vector are supplied supercoiled and lyophilized.

Specifically designed for use in the development of DNA vaccines

• Features eukaryotic DNA sequences limited to those required for expression in order to minimize possibility of chromosomal integration
• Kanamycin resistance gene for selection in E. coli because ampicillin has been reported to cause allergic response in some individuals
• Expression levels of recombinant proteins from pVAX1 comparable to those achieved with its parent vector, pcDNA™3.1
• Small size of pVAX1 and the variety of unique cloning sites simplify subcloning of even very large DNA fragments

Bioproduction, Constitutive Expression, Mammalian Expression, Protein Expression, Proteins, Expression, Isolation and Analysis, Viral Vaccine Production

Specifications

• Constitutive or Inducible System: Constitutive
• Delivery Type: Transfection
• Promoter: CMV
• Product Type: Viral Vaccine Vector
• Selection Agent (Eukaryotic): None
• Content And Storage: 20 μg of each pVAX1 and expression control vector are supplied supercoiled and lyophilized. Store at -20°C. Vector is guaranteed stable for 6 months when properly stored.
• Protein Tag: Untagged
• Cloning Method: Restriction Enzyme/MCS
• Quantity: 20 μg
• Vector: pVAX1
• Product Line: pVAX

For Research Use Only. Not for use in diagnostic procedures.